Ginsenoside Rg3 targets glycosylation of PD-L1 to enhance anti-tumor immunity in non-small cell lung cancer
These results suggest that Rg3 inhibits PD-L1 glycosylation and thus enhance anti-tumor immunity, which provide new therapeutic insight into drug discovery.
Authors
- Min Kong (ORCID: https://orcid.org/0000-0002-4884-6991)
- Fu Shen
- Weichun Li (ORCID: https://orcid.org/0000-0003-0154-861X)
- Wei Wang (ORCID: https://orcid.org/0000-0001-6043-0860)
- Cheng Chen (ORCID: https://orcid.org/0000-0003-3662-0263)
- Ping Li (ORCID: https://orcid.org/0000-0003-1055-9505)
- Cheng Li (ORCID: https://orcid.org/0000-0003-0159-7294)
- Liang Yang (ORCID: https://orcid.org/0000-0003-0632-7568)
- Aihua Zhong
- Zhiqiang Qian
- Yuhua Wang (ORCID: https://orcid.org/0009-0004-7208-7202)
- Yueqin Li
- Fangkai He
Institutions
- Nanjing University of Chinese Medicine (CN)
- Second Military Medical University (CN)
- Nantong University (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Jiangning District of Nanjing Chinese Medicine Hospital (CN)
- Changhai Hospital (CN)
- The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN)
- Traditional Chinese Medicine Hospital of Kunshan (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-08-23
- DOI
- https://doi.org/10.3389/fimmu.2024.1434078
- Citations
- 17
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 4.09